Shay Capital »

Keros Therapeutics shares owned by Shay Capital

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Shay Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $192k 19k 10.19

More positions owned by Shay Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Purecycle Technologies (PCT)
Ishares Silver Tr Ishares (SLV)
Ftai Aviation SHS (FTAI)
Vor Biopharma Com New Call Option
Sable Offshore Corp Com Shs (SOC)
First Solar (FSLR)
Tesla Motors (TSLA)
Warner Bros Discovery Com Ser A (WBD)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alibaba Group Hldg Sponsored Ads (BABA)
Agnc Invt Corp Com reit (AGNC)
Jd.com Spon Ads Cl A (JD)
A2z Cust2mate Solutions Corp (AZ)

View all positions for Shay Capital

Top funds holding Keros Therapeutics

ADAR1 Capital Management
Vanguard Group
BlackRock
Madison Avenue Partners
Western Standard
Nantahala Capital Management
Tang Capital Management
D. E. Shaw & Co
Goldman Sachs Group
State Street Corporation
OrbiMed Advisors
Alkeon Capital Management
Logos Global Management
Geode Capital Management
Susquehanna International

View all funds holding Keros Therapeutics